Rapid Micro Biosystems to Attend Morgan Stanley’s 22nd Annual Global Healthcare Conference

LEXINGTON, Mass., Sept. 3, 2024 (GLOBE NEWSWIRE) — Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company delivering mission-critical automation solutions to facilitate the efficient manufacturing and rapid, safe release of healthcare products, today announced that the Company will participate in the Morgan Stanley 22^nd
Annual Global Healthcare Conference on Friday, September 6, 2024 in New York City.

Rob Spignesi, President and CEO, and Sean Wirtjes, CFO, are expected to participate in a 35-minute question-and-answer session with the host analyst at 7:00 a.m. Eastern Time. A live webcast of the session will be available on the Rapid Micro Biosystems investor relations website at https://investors.rapidmicrobio.com/ and can be accessed here. The webcast will be archived and available for replay following the event.